Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,238 | -84,604 | -43,099 | -58,900 | -35,374 |
| Depreciation Amortization | 377 | 183 | 2,033 | 3,395 | 2,472 |
| Income taxes - deferred | N/A | N/A | -513 | 6 | 8 |
| Accounts receivable | 84 | 10,042 | -7,826 | -1,569 | 1,131 |
| Accounts payable and accrued liabilities | -374 | 261 | -2,441 | 1,765 | 2,944 |
| Other Working Capital | -61,993 | -7,978 | 189,965 | 43,260 | -248 |
| Other Operating Activity | 23,664 | 6,575 | 32,254 | 10,011 | 1,652 |
| Operating Cash Flow | $-140,480 | $-75,521 | $170,373 | $-2,032 | $-27,415 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,198 | 9,714 | -119,707 | 47,983 | -128,151 |
| PPE Investments | -3,497 | -3,788 | -1,559 | -2,124 | -1,594 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -817 |
| Investing Cash Flow | $79,701 | $5,926 | $-121,266 | $45,859 | $-130,562 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -3,067 |
| Common Stock Issued | 1,627 | 139,624 | 23,796 | 930 | 82,040 |
| Other Financing Activity | 0 | 0 | 0 | 66 | 74,430 |
| Financing Cash Flow | $1,627 | $139,624 | $23,796 | $996 | $153,403 |
| Beginning Cash Position | 248,494 | 178,465 | 105,562 | 60,739 | 64,396 |
| End Cash Position | 189,342 | 248,494 | 178,465 | 105,562 | 59,822 |
| Net Cash Flow | $-59,152 | $70,029 | $72,903 | $44,823 | $-4,574 |
| Free Cash Flow | |||||
| Operating Cash Flow | -140,480 | -75,521 | 170,373 | -2,032 | -27,415 |
| Capital Expenditure | -3,497 | -3,788 | -1,559 | -2,176 | -1,594 |
| Free Cash Flow | -143,977 | -79,309 | 168,814 | -4,208 | -29,009 |